{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:51:33Z","timestamp":1792439493709,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG47812"],"award-info":[{"award-number":["R01AG47812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG066347"],"award-info":[{"award-number":["AG066347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG069333"],"award-info":[{"award-number":["AG069333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG060767"],"award-info":[{"award-number":["AG060767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS105473"],"award-info":[{"award-number":["R01NS105473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG042178"],"award-info":[{"award-number":["R01AG042178"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K99AG065645"],"award-info":[{"award-number":["K99AG065645"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.redox.2021.102182","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T21:35:35Z","timestamp":1636407335000},"page":"102182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Subodh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Orlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd E","family":"Bunquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangampalli Adi","family":"Pradeepkiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Alvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9560-9948","authenticated-orcid":false,"given":"P. Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2021.102182_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.redox.2021.102182_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1602\/neurorx.1.1.111","article-title":"Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations","volume":"1","author":"Mattson","year":"2004","journal-title":"NeuroRx"},{"issue":"7","key":"10.1016\/j.redox.2021.102182_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-beta in Alzheimer's disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.redox.2021.102182_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbadis.2011.10.011","article-title":"Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics","volume":"1822","author":"Reddy","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 2","key":"10.1016\/j.redox.2021.102182_bib5","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.3233\/JAD-2010-100504","article-title":"Amyloid beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline","volume":"20","author":"Reddy","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.redox.2021.102182_bib6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.redox.2021.102182_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.irn.2020.01.008","article-title":"The mitochondrial hypothesis: dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease","volume":"154","author":"Swerdlow","year":"2020","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.redox.2021.102182_bib8","doi-asserted-by":"crossref","first-page":"113321","DOI":"10.1016\/j.expneurol.2020.113321","article-title":"Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis","volume":"330","author":"Weidling","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.redox.2021.102182_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.redox.2021.102182_bib10","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1172\/JCI137908","article-title":"Isoform-specific roles of AMPK catalytic \u03b1 subunits in Alzheimer's disease","volume":"130","author":"Zhao","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.redox.2021.102182_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/cells9041065","article-title":"Altered mitochondrial dynamics in motor neuron disease: an emerging perspective","volume":"9","author":"Kodavati","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.redox.2021.102182_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.expneurol.2010.04.018","article-title":"Beyond the signaling effect role of amyloid-\u00df42 on the processing of APP, and its clinical implications","volume":"225","author":"Lahiri","year":"2010","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.redox.2021.102182_bib13","doi-asserted-by":"crossref","first-page":"88995","DOI":"10.1016\/j.bbrc.2010.12.053","article-title":"MicroRNA-101 downregulates Alzheimer's amyloid-\u03b2 precursor protein levels in human cell cultures and is differentially expressed","volume":"404","author":"Long","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.redox.2021.102182_bib14","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M110.112664","article-title":"MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons","volume":"285","author":"Vilardo","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.redox.2021.102182_bib15","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1523\/JNEUROSCI.2053-15.2015","article-title":"microRNA-33 regulates ApoE lipidation and amyloid-\u03b2 metabolism in the brain","volume":"35","author":"Kim","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.redox.2021.102182_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2017.09.043","article-title":"MicroRNA-125b promotes neurons cell apoptosis and Ta phosphorylation in Alzheimer's disease","volume":"661","author":"Ma","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.redox.2021.102182_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41380-018-0266-3","article-title":"Novel upregulation of amyloid-\u03b2 precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5\u2032-untranslated region: implications in Alzheimer's disease","volume":"3","author":"Long","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.redox.2021.102182_bib18","article-title":"MicroRNA-298 reduces levels of human amyloid-\u03b2 precursor protein (APP), \u03b2-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties","volume":"Jan 15","author":"Chopra","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.redox.2021.102182_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fneur.2020.00462","article-title":"microRNA-146a signaling in Alzheimer's disease (AD) and prion disease (PrD)","volume":"25","author":"Lukiw","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.redox.2021.102182_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fneur.2019.00028","article-title":"microRNA-34a (miRNA-34a) mediated down-regulation of the post-synaptic cytoskeletal element SHANK3 in sporadic Alzheimer's disease (AD)","volume":"10","author":"Zhao","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.redox.2021.102182_bib21","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.3233\/JAD-190583","article-title":"A new discovery of MicroRNA-455-3p in alzheimer's disease","volume":"72","author":"Kumar","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.redox.2021.102182_bib22","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15252\/embr.201540837","article-title":"MicroRNA-455 regulates brown adipogenesis via a novel HIF1an-AMPK-PGC1\u03b1 signaling network","volume":"16","author":"Zhang","year":"2015","journal-title":"EMBO Rep"},{"key":"10.1016\/j.redox.2021.102182_bib23","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.redox.2021.102182_bib24","article-title":"MicroRNA-455-3p as a potential biomarker for alzheimer's disease: an update","volume":"23","author":"Kumar","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.redox.2021.102182_bib25","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.bbadis.2019.06.006","article-title":"Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease","volume":"1865","author":"Kumar","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.redox.2021.102182_bib26","doi-asserted-by":"crossref","first-page":"166052","DOI":"10.1016\/j.bbadis.2020.166052","article-title":"Elevated levels of MicroRNA-455-3p in the cerebrospinal fluid of Alzheimer's patients: a potential biomarker for Alzheimer's disease","volume":"1867","author":"Kumar","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.redox.2021.102182_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-021-02360-7","article-title":"Anti-brain aging effects of small molecule inhibitor DDQ","author":"Vijayan","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.redox.2021.102182_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mito.2021.04.005","article-title":"Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer's disease","volume":"59","author":"Vijayan","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.redox.2021.102182_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/msj.20159","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"77","author":"Elder","year":"2010","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.redox.2021.102182_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","article-title":"Mouse models of Alzheimer's disease","volume":"88","author":"Hall","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.redox.2021.102182_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.acr.2017.06.006","article-title":"Animal models to study MicroRNA function","volume":"135","author":"Pal","year":"2017","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.redox.2021.102182_bib32","doi-asserted-by":"crossref","first-page":"894938","DOI":"10.4061\/2011\/894938","article-title":"MicroRNAs and alzheimer's disease mouse models: current insights and future research avenues","author":"Delay","year":"2011","journal-title":"Int J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.redox.2021.102182_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.redox.2021.102182_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fphar.2016.00329","article-title":"MicroRNA-based therapy in animal models of selected gastrointestinal cancers","volume":"7","author":"Merhautova","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.redox.2021.102182_bib35","doi-asserted-by":"crossref","first-page":"a016824","DOI":"10.1101\/cshperspect.a016824","article-title":"Synaptic signaling in learning and memory","volume":"8","author":"Kennedy","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.redox.2021.102182_bib36","doi-asserted-by":"crossref","first-page":"165937","DOI":"10.1016\/j.bbadis.2020.165937","article-title":"The role of synaptic microRNAs in Alzheimer's disease","volume":"1866","author":"Kumar","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.redox.2021.102182_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2019.21.3\/whoner","article-title":"The synaptic pathology of cognitive life","volume":"21","author":"Honer","year":"2019","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.redox.2021.102182_bib38","doi-asserted-by":"crossref","first-page":"101208","DOI":"10.1016\/j.arr.2020.101208","article-title":"Synaptic basis of Alzheimer's disease: focus on synaptic amyloid beta, P-tau and mitochondria","volume":"65","author":"John","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.redox.2021.102182_bib39","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/ncomms2238","article-title":"Involvement of PGC-1\u03b1 in the formation and maintenance of neuronal dendritic spines","volume":"3","author":"Cheng","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.redox.2021.102182_bib40","doi-asserted-by":"crossref","first-page":"116819","DOI":"10.1016\/j.lfs.2019.116819","article-title":"Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p\/HDAC2","volume":"235","author":"Guo","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.redox.2021.102182_bib41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/1354750X.2020.1832147","article-title":"miR-455-3p alleviates propofol-induced neurotoxicity by reducing EphA4 expression in developing neurons","volume":"25","author":"Zhu","year":"2020","journal-title":"Biomarkers"},{"key":"10.1016\/j.redox.2021.102182_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.redox.2021.102182_bib43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbadis.2011.01.007","article-title":"Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons","volume":"1812","author":"Calkins","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.redox.2021.102182_bib44","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1073\/pnas.0808801106","article-title":"PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells","volume":"106","author":"O'Hagan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.redox.2021.102182_bib45","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.21873\/anticanres.13672","article-title":"Hypoxia-induced PGC-1\u03b1 regulates mitochondrial function and tumorigenesis of colorectal cancer cells","volume":"39","author":"Yun","year":"2019","journal-title":"Anticancer Res"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:59:45Z","timestamp":1778853585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721003426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"alternative-id":["S2213231721003426"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.102182","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-455-3p improves synaptic, cognitive functions and extends lifespan: Relevance to Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.102182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102182"}}